Clinical Trial Update: Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating thiotepa-based conditioning for allogeneic stem-cell transplantation in lymphoid malignancies, including non-Hodgkin lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Sheba Medical Center | Conditions: Non Hodgkin Lymphoma, Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN